STOCK TITAN

Arxis, Inc. Form 4 Filings

ARXS NASDAQ

Every Form 4 that Arxis, Inc. (ARXS) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow ARXS and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ARXS filings page.

Rhea-AI Summary

Arxis, Inc. (symbol: ARXS) is the issuer of record for a Form 4 filing submitted to the SEC.

Rhea-AI Summary

Jankowski Ryan Anthony reported acquisition or exercise transactions in this Form 4 filing.

Arxis, Inc. Chief Accounting Officer Ryan Anthony Jankowski received a grant of 8,517 restricted stock units of Class A Common Stock on June 29, 2026, at no cash cost. These units vest in three substantially equal annual installments on June 23, 2027, June 23, 2028, and June 23, 2029, subject to continued employment. Following this equity award, Jankowski directly holds 59,848 shares of Class A Common Stock.

Rhea-AI Summary

Arxis, Inc. Chief Accounting Officer Ryan Anthony Jankowski reported two Class A Common Stock transactions connected to the company’s initial public offering. On April 16, he acquired 46,867 shares at $0.00 per share as an award of restricted stock that remains subject to time-vesting conditions, issued in replacement of equivalent equity interests in a subsidiary following the issuer’s reorganization for the IPO. On April 17, he made an open‑market purchase of 4,464 shares at $28.00 per share through the directed share program conducted in connection with the IPO. After these transactions, he directly owned 51,331 shares of Class A Common Stock.

Rhea-AI Summary

Allen Jennifer H. reported acquisition or exercise transactions in this Form 4 filing.

Arxis, Inc. reported that officer Jennifer H. Allen received an award of 53,695 shares of Class A Common Stock as restricted stock. The shares were granted at no cash cost and remain subject to time-based vesting conditions.

The filing explains that this restricted stock award replaces equity interests she previously held in a subsidiary of Arxis, following a reorganization connected to Arxis’s initial public offering. After this award, the filing shows Allen directly holding 53,695 Class A shares.

Rhea-AI Summary

Arxis, Inc. officer Badakhsh Azad Sid increased his direct stake in Class A Common Stock through an IPO-related equity award and a share purchase. He received an award covering 367,864 shares of restricted stock, of which 331,080 shares remain subject to time-vesting conditions.

He also made an open-market-style purchase of 36,000 Class A shares at $28.00 per share through the directed share program tied to the company’s initial public offering. Following these transactions, he directly holds a total of 403,864 Class A shares.

Rhea-AI Summary

Arxis, Inc. officer Ross Bradley Sealfon reported two transactions in Class A Common Stock. On April 16, 2026, he received 1,090,307 shares through a restricted stock award replacing equivalent equity interests in a subsidiary as part of the company’s initial public offering reorganization; 775,067 shares remain subject to time-vesting conditions.

On April 17, 2026, he made an open-market purchase of 12,500 shares at $28.00 per share through the IPO’s directed share program, bringing his direct holdings to 1,102,807 shares of Class A Common Stock.

Rhea-AI Summary

Arxis, Inc. director Stephen Duane Oetgen reported new investments in the company’s Class A Common Stock. He made an open-market purchase of 25,000 shares at $28.00 per share, and after this trade he directly holds 30,357 shares.

Separately, he received a grant of 5,357 restricted stock units, which will vest on the first anniversary of the grant date. The purchased shares were acquired through the directed share program conducted in connection with Arxis’s initial public offering.

Rhea-AI Summary

Arxis, Inc. director ALLEN PATRICK E increased his direct stake in the company. He made an open-market purchase of 10,000 shares of Class A Common Stock at $28.00 per share on April 17, 2026, bringing his direct holdings to 15,357 shares after the transaction.

He also received a grant of 5,357 restricted stock units, which will vest on the first anniversary of the grant date. The purchased shares were acquired through the directed share program conducted in connection with Arxis, Inc.'s initial public offering.

Rhea-AI Summary

Arxis, Inc. director and officer Kevin Scott Perhamus reported two equity acquisitions in Class A Common Stock. On April 16, 2026, he received a grant/award of 3,519,533 shares at $0.00 per share, reflecting equity issued in connection with Arxis’s initial public offering reorganization. This total includes shares of restricted stock, with 1,357,902 shares still subject to time-vesting conditions.

On April 17, 2026, he made an open-market purchase of 53,600 shares at $28.00 per share through the IPO directed share program. Following these transactions, he directly holds 3,573,133 shares of Arxis Class A Common Stock.

Rhea-AI Summary

Arxis, Inc. officer Jason Aaron Roth reported two recent transactions in Class A Common Stock. On April 17, 2026, he made an open-market purchase of 60,000 shares at $28.00 per share, bringing his direct holdings to 395,515 shares.

On April 16, 2026, he received a grant of 335,515 shares of Class A Common Stock at no cost, issued in connection with a reorganization tied to the company’s initial public offering. This grant includes 204,591 restricted shares that remain subject to time-vesting conditions. The 60,000 purchased shares were acquired through the directed share program associated with the IPO.

Rhea-AI Summary

Arxis, Inc. reported insider acquisitions linked to its initial public offering and capital structure. Reporting entities associated with Arcline and Engineered Components were granted 340,676,786 shares of Class B Common Stock, issued in replacement of equity interests in certain subsidiaries as part of a reorganization connected to the IPO. These Class B shares are convertible into Class A Common Stock on a one-for-one basis at the option of the holders and automatically convert in certain transfer and other circumstances. In addition, one share of Convertible Common Stock was awarded, held by Arcline Arxis Advisory I, L.P., indirectly controlled by Rajeev Amara and Shyam Ravindran. This Convertible Common Stock is designed to convert into Class B (or Class A) shares based on a formula referencing 1.25% of fully diluted capital stock, the stock price, and an IPO price of $28, with voluntary conversion generally permitted from April 17, 2031 to April 17, 2036 and automatic conversion upon certain change of control events after April 20, 2029.